Stock Price
76.60
Daily Change
0.66 0.87%
Monthly
5.39%
Yearly
-20.88%
Q1 Forecast
73.40

Symrise reported EUR1.22B in Sales Revenues for its fiscal semester ending in September of 2025.





Sales Change Date
Avient USD 761M 46M Dec/2025
Chemours USD 1.3B 200M Dec/2025
Corteva USD 3.91B 1.29B Dec/2025
Covestro EUR 3.17B 210M Sep/2025
Symrise EUR 1.22B 1.33B Sep/2025
Victrex GBP 75.5M 70.4M Sep/2025